| [1] |
阮继生. “伯杰氏系统细菌学手册(第二版)”第5卷与我国的放线菌系统学研究[J]. 微生物学报, 2013, 53(6):521-530.
|
| [2] |
JAMES H J, KAREN C C, GUIDO F, et al. Manual of clinical microbiology[M]. 11th ed. New York: Wiley, 2015.
|
| [3] |
LUGLI G A, MILANI C, TURRONI F, et al. Comparative genomic and phylogenomic analyses of the Bifidobacteriaceae family[J]. BMC Genomics, 2017, 18(1):568.
|
| [4] |
CARDONA-BENAVIDES I, PUERTAS-PRIETO A, PINILLA-MARTÍN F J, et al. Alloscardovia omnicolens emerging presence in premature rupture of membranes[J]. New Microbiol, 2019, 42(4):237-239.
|
| [5] |
TAKIGUCHI Y, NAGAYOSHI M, MATSUURA Y, et al. Thoracic empyema caused by Alloscardovia omnicolens and Bifidobacteriumdentium[J]. J Infect Chemother, 2022, 28(11):1567-1570.
|
| [6] |
OGAWA Y, KOIZUMI A, KASAHARA K, et al. Bacteremia secondary to Alloscardovia omnicolens urinary tract infection[J]. J Infect Chemother, 2016, 22(6):424-425.
|
| [7] |
HUYS G, VANCANNEYT M,D'HAENE K,et al. Alloscardovia omnicolens gen. nov.,sp. nov.,from human clinical samples[J]. Int J Syst Evol Microbiol, 2007, 57(Pt 7):1442-1446.
|
| [8] |
BROWN M K, FORBES B A, STITLEY K, et al. Defining the clinical significance of Alloscardovia omnincolens in the urinary tract[J]. J Clin Microbiol, 2016, 54(6):1552-1556.
|
| [9] |
MAHLEN S D, CLARRIDGE J E 3rd. Site and clinical significance of Alloscardovia omnicolens and Bifidobacterium species isolated in the clinical laboratory[J]. J Clin Microbiol, 2009, 47(10):3289-3293.
|
| [10] |
JOHNSON M J, THATCHER E, COX M E. Techniques for controlling variability in gram staining of obligate anaerobes[J]. J Clin Microbiol, 1995, 33(3):755-758.
DOI
PMID
|
| [11] |
WOO P C, WONG S S, LUM P N, et al. Cell-wall-deficient bacteria and culture-negative febrile episodes in bone-marrow-transplant recipients[J]. Lancet, 2001, 357(9257):675-679.
PMID
|
| [12] |
KAWAI Y, MICKIEWICZ K, ERRINGTON J. Lysozyme counteracts β-Lactam antibiotics by promoting the emergence of L-Form bacteria[J]. Cell, 2018, 172(5):1038-1049.
DOI
PMID
|
| [13] |
LAZENBY J J, LI E S, WHITCHURCH C B. Cell wall deficiency - an alternate bacterial lifestyle?[J]. Microbiology(Reading), 2022, 168(8):1218.
|
| [14] |
ISNARD C, LIENHARD R, REISSIER S, et al. In vitro antimicrobial susceptibility of Alloscardovia omnicolens and molecular mechanisms of acquired resistance[J]. Diagn Microbiol Infect Dis, 2016, 84(3):227-229.
|
